CML announced that, further to the announcement on 2 October 2023, Dr Nathan Zommer has now been appointed to the board of the Company in a non-executive capacity, effective from 1 January 2024, following completion of the normal regulatory due diligence checks.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
380 GBX | 0.00% | -1.30% | +1.60% |
Mar. 26 | CML Microsystems expects revenue growth despite weak trading | AN |
2023 | CML Appoints Dr Nathan Zommer to the Board as Non-Executive, Effective from 1 January 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.60% | 77.97M | |
+123.34% | 2,716B | |
+41.32% | 671B | |
+22.19% | 632B | |
+13.15% | 270B | |
+41.61% | 229B | |
+14.88% | 178B | |
+47.94% | 140B | |
-39.92% | 129B | |
+60.72% | 126B |
- Stock Market
- Equities
- CML Stock
- News CML Microsystems plc
- CML Appoints Dr Nathan Zommer to the Board as Non-Executive, Effective from 1 January 2024